CA2687637A1 - Echafaudages partiellement degradables pour applications biomedicales - Google Patents

Echafaudages partiellement degradables pour applications biomedicales Download PDF

Info

Publication number: CA2687637A1
Authority: CA; Canada
Prior art keywords: scaffold; material layer; bioactive material; bioactive; tissue
Prior art date: 2007-05-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002687637A

Other languages

English (en)

Inventor

Soheil Asgari

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cinvention AG

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-22

Filing date

2008-05-21

Publication date

2008-11-27

2008-05-21 Application filed by Individual filed Critical Individual

2008-11-27 Publication of CA2687637A1 publication Critical patent/CA2687637A1/fr

Status Abandoned legal-status Critical Current

Links

239000000463 material Substances 0.000 claims abstract description 218
230000000975 bioactive effect Effects 0.000 claims abstract description 135
230000015556 catabolic process Effects 0.000 claims abstract description 38
238000006731 degradation reaction Methods 0.000 claims abstract description 38
210000004027 cell Anatomy 0.000 claims description 117
-1 cadhereins Proteins 0.000 claims description 99
229910052751 metal Inorganic materials 0.000 claims description 69
239000002184 metal Substances 0.000 claims description 69
239000002245 particle Substances 0.000 claims description 54
238000000034 method Methods 0.000 claims description 41
150000002500 ions Chemical class 0.000 claims description 30
239000011777 magnesium Substances 0.000 claims description 25
239000002131 composite material Substances 0.000 claims description 21
229910052749 magnesium Inorganic materials 0.000 claims description 21
210000000056 organ Anatomy 0.000 claims description 21
239000000956 alloy Substances 0.000 claims description 20
239000011148 porous material Substances 0.000 claims description 19
239000003795 chemical substances by application Substances 0.000 claims description 18
150000001875 compounds Chemical class 0.000 claims description 18
229910001092 metal group alloy Inorganic materials 0.000 claims description 18
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 17
239000013543 active substance Substances 0.000 claims description 17
238000004113 cell culture Methods 0.000 claims description 16
239000003575 carbonaceous material Substances 0.000 claims description 15
102000004169 proteins and genes Human genes 0.000 claims description 15
108090000623 proteins and genes Proteins 0.000 claims description 15
229910052742 iron Inorganic materials 0.000 claims description 14
239000011575 calcium Substances 0.000 claims description 13
238000000576 coating method Methods 0.000 claims description 13
239000011248 coating agent Substances 0.000 claims description 12
230000006870 function Effects 0.000 claims description 12
239000007788 liquid Substances 0.000 claims description 12
230000009286 beneficial effect Effects 0.000 claims description 11
229910052791 calcium Inorganic materials 0.000 claims description 11
239000011368 organic material Substances 0.000 claims description 10
150000003839 salts Chemical class 0.000 claims description 9
229910052710 silicon Inorganic materials 0.000 claims description 9
229910000861 Mg alloy Inorganic materials 0.000 claims description 8
229910052725 zinc Inorganic materials 0.000 claims description 8
239000011701 zinc Substances 0.000 claims description 8
239000000654 additive Substances 0.000 claims description 7
229910010272 inorganic material Inorganic materials 0.000 claims description 7
239000011147 inorganic material Substances 0.000 claims description 7
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
229910052784 alkaline earth metal Inorganic materials 0.000 claims description 6
229910052782 aluminium Inorganic materials 0.000 claims description 6
238000003306 harvesting Methods 0.000 claims description 6
229910052721 tungsten Inorganic materials 0.000 claims description 6
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
150000001342 alkaline earth metals Chemical class 0.000 claims description 5
229910010293 ceramic material Inorganic materials 0.000 claims description 5
239000012528 membrane Substances 0.000 claims description 5
229910052717 sulfur Inorganic materials 0.000 claims description 5
229910019142 PO4 Inorganic materials 0.000 claims description 4
230000008859 change Effects 0.000 claims description 4
229910052588 hydroxylapatite Inorganic materials 0.000 claims description 4
102000006240 membrane receptors Human genes 0.000 claims description 4
108020004084 membrane receptors Proteins 0.000 claims description 4
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 4
238000000926 separation method Methods 0.000 claims description 4
239000011593 sulfur Substances 0.000 claims description 4
102000027257 transmembrane receptors Human genes 0.000 claims description 4
108091008578 transmembrane receptors Proteins 0.000 claims description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
229910002651 NO3 Inorganic materials 0.000 claims description 3
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 3
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 3
210000001124 body fluid Anatomy 0.000 claims description 3
239000010839 body fluid Substances 0.000 claims description 3
150000001720 carbohydrates Chemical class 0.000 claims description 3
235000014633 carbohydrates Nutrition 0.000 claims description 3
230000000593 degrading effect Effects 0.000 claims description 3
229910001385 heavy metal Inorganic materials 0.000 claims description 3
102000006495 integrins Human genes 0.000 claims description 3
108010044426 integrins Proteins 0.000 claims description 3
150000002632 lipids Chemical class 0.000 claims description 3
239000013528 metallic particle Substances 0.000 claims description 3
230000004820 osteoconduction Effects 0.000 claims description 3
239000002861 polymer material Substances 0.000 claims description 3
229910052761 rare earth metal Inorganic materials 0.000 claims description 3
150000002910 rare earth metals Chemical class 0.000 claims description 3
229910052708 sodium Inorganic materials 0.000 claims description 3
239000011734 sodium Substances 0.000 claims description 3
229930186217 Glycolipid Natural products 0.000 claims description 2
102000003886 Glycoproteins Human genes 0.000 claims description 2
108090000288 Glycoproteins Proteins 0.000 claims description 2
102000004895 Lipoproteins Human genes 0.000 claims description 2
108090001030 Lipoproteins Proteins 0.000 claims description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
102000003800 Selectins Human genes 0.000 claims description 2
108090000184 Selectins Proteins 0.000 claims description 2
210000003976 gap junction Anatomy 0.000 claims description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
239000010452 phosphate Substances 0.000 claims description 2
229910052700 potassium Inorganic materials 0.000 claims description 2
239000011591 potassium Substances 0.000 claims description 2
238000003980 solgel method Methods 0.000 claims description 2
210000001578 tight junction Anatomy 0.000 claims description 2
230000000996 additive effect Effects 0.000 claims 1
239000011256 inorganic filler Substances 0.000 claims 1
229910003475 inorganic filler Inorganic materials 0.000 claims 1
239000000696 magnetic material Substances 0.000 claims 1
229910000510 noble metal Inorganic materials 0.000 claims 1
239000012766 organic filler Substances 0.000 claims 1
210000001519 tissue Anatomy 0.000 description 88
239000008279 sol Substances 0.000 description 55
239000000499 gel Substances 0.000 description 47
239000000203 mixture Substances 0.000 description 46
229920000642 polymer Polymers 0.000 description 42
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 39
229910052799 carbon Inorganic materials 0.000 description 24
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 23
239000012530 fluid Substances 0.000 description 22
239000002609 medium Substances 0.000 description 21
210000000988 bone and bone Anatomy 0.000 description 20
150000002739 metals Chemical class 0.000 description 20
239000000126 substance Substances 0.000 description 16
229910045601 alloy Inorganic materials 0.000 description 15
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 15
238000001727 in vivo Methods 0.000 description 14
235000018102 proteins Nutrition 0.000 description 14
229910044991 metal oxide Inorganic materials 0.000 description 13
150000004706 metal oxides Chemical class 0.000 description 13
150000004703 alkoxides Chemical class 0.000 description 12
229910003472 fullerene Inorganic materials 0.000 description 12
239000007787 solid Substances 0.000 description 12
241000282414 Homo sapiens Species 0.000 description 11
229910021397 glassy carbon Inorganic materials 0.000 description 11
239000011159 matrix material Substances 0.000 description 11
230000012010 growth Effects 0.000 description 10
230000008569 process Effects 0.000 description 10
XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 9
241001465754 Metazoa Species 0.000 description 9
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 9
239000006096 absorbing agent Substances 0.000 description 9
239000012620 biological material Substances 0.000 description 9
238000007796 conventional method Methods 0.000 description 9
239000002904 solvent Substances 0.000 description 9
210000000845 cartilage Anatomy 0.000 description 8
238000009826 distribution Methods 0.000 description 8
230000003301 hydrolyzing effect Effects 0.000 description 8
229910052697 platinum Inorganic materials 0.000 description 8
239000004065 semiconductor Substances 0.000 description 8
239000000243 solution Substances 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
239000002253 acid Substances 0.000 description 7
229920001577 copolymer Polymers 0.000 description 7
239000003102 growth factor Substances 0.000 description 7
230000008439 repair process Effects 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
239000004480 active ingredient Substances 0.000 description 6
125000004432 carbon atom Chemical group C* 0.000 description 6
239000000919 ceramic Substances 0.000 description 6
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 6
239000003814 drug Substances 0.000 description 6
239000000945 filler Substances 0.000 description 6
238000006460 hydrolysis reaction Methods 0.000 description 6
239000007943 implant Substances 0.000 description 6
238000011068 loading method Methods 0.000 description 6
230000005291 magnetic effect Effects 0.000 description 6
229910052759 nickel Inorganic materials 0.000 description 6
UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 5
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
150000001242 acetic acid derivatives Chemical class 0.000 description 5
150000001450 anions Chemical class 0.000 description 5
229910052804 chromium Inorganic materials 0.000 description 5
239000011651 chromium Substances 0.000 description 5
229910017052 cobalt Inorganic materials 0.000 description 5
239000010941 cobalt Substances 0.000 description 5
238000012258 culturing Methods 0.000 description 5
239000000032 diagnostic agent Substances 0.000 description 5
229940039227 diagnostic agent Drugs 0.000 description 5
239000007789 gas Substances 0.000 description 5
229910052737 gold Inorganic materials 0.000 description 5
239000010931 gold Substances 0.000 description 5
239000001963 growth medium Substances 0.000 description 5
210000003494 hepatocyte Anatomy 0.000 description 5
230000007062 hydrolysis Effects 0.000 description 5
239000002071 nanotube Substances 0.000 description 5
150000004767 nitrides Chemical class 0.000 description 5
210000000963 osteoblast Anatomy 0.000 description 5
229920001308 poly(aminoacid) Polymers 0.000 description 5
229920000747 poly(lactic acid) Polymers 0.000 description 5
239000002243 precursor Substances 0.000 description 5
239000010703 silicon Substances 0.000 description 5
239000004071 soot Substances 0.000 description 5
210000000130 stem cell Anatomy 0.000 description 5
239000000725 suspension Substances 0.000 description 5
239000010936 titanium Substances 0.000 description 5
229910000859 α-Fe Inorganic materials 0.000 description 5
102000008186 Collagen Human genes 0.000 description 4
108010035532 Collagen Proteins 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
239000002250 absorbent Substances 0.000 description 4
230000002745 absorbent Effects 0.000 description 4
239000004964 aerogel Substances 0.000 description 4
230000032683 aging Effects 0.000 description 4
235000001014 amino acid Nutrition 0.000 description 4
150000001413 amino acids Chemical class 0.000 description 4
229920002988 biodegradable polymer Polymers 0.000 description 4
239000004621 biodegradable polymer Substances 0.000 description 4
150000001722 carbon compounds Chemical class 0.000 description 4
238000003763 carbonization Methods 0.000 description 4
150000001735 carboxylic acids Chemical class 0.000 description 4
150000001768 cations Chemical class 0.000 description 4
230000010261 cell growth Effects 0.000 description 4
229920001436 collagen Polymers 0.000 description 4
229910052802 copper Inorganic materials 0.000 description 4
239000010949 copper Substances 0.000 description 4
230000004069 differentiation Effects 0.000 description 4
229940079593 drug Drugs 0.000 description 4
238000001035 drying Methods 0.000 description 4
150000002148 esters Chemical class 0.000 description 4
239000000835 fiber Substances 0.000 description 4
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
239000010439 graphite Substances 0.000 description 4
229910002804 graphite Inorganic materials 0.000 description 4
230000001939 inductive effect Effects 0.000 description 4
230000001788 irregular Effects 0.000 description 4
210000003734 kidney Anatomy 0.000 description 4
150000002681 magnesium compounds Chemical class 0.000 description 4
229910052748 manganese Inorganic materials 0.000 description 4
239000011572 manganese Substances 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
150000001247 metal acetylides Chemical class 0.000 description 4
150000002736 metal compounds Chemical class 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
239000000178 monomer Substances 0.000 description 4
239000002105 nanoparticle Substances 0.000 description 4
229920000620 organic polymer Polymers 0.000 description 4
230000008520 organization Effects 0.000 description 4
230000036961 partial effect Effects 0.000 description 4
238000012545 processing Methods 0.000 description 4
239000000047 product Substances 0.000 description 4
229910052709 silver Inorganic materials 0.000 description 4
239000000758 substrate Substances 0.000 description 4
229910052715 tantalum Inorganic materials 0.000 description 4
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 4
230000008685 targeting Effects 0.000 description 4
GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 4
239000010937 tungsten Substances 0.000 description 4
241000234282 Allium Species 0.000 description 3
235000002732 Allium cepa var. cepa Nutrition 0.000 description 3
102000016289 Cell Adhesion Molecules Human genes 0.000 description 3
108010067225 Cell Adhesion Molecules Proteins 0.000 description 3
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
108010049003 Fibrinogen Proteins 0.000 description 3
102000008946 Fibrinogen Human genes 0.000 description 3
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 3
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
150000008065 acid anhydrides Chemical class 0.000 description 3
150000001412 amines Chemical class 0.000 description 3
229910003481 amorphous carbon Inorganic materials 0.000 description 3
238000009412 basement excavation Methods 0.000 description 3
229920000249 biocompatible polymer Polymers 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
239000003054 catalyst Substances 0.000 description 3
230000021164 cell adhesion Effects 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
210000001612 chondrocyte Anatomy 0.000 description 3
238000003501 co-culture Methods 0.000 description 3
230000001054 cortical effect Effects 0.000 description 3
238000004132 cross linking Methods 0.000 description 3
230000006378 damage Effects 0.000 description 3
230000002950 deficient Effects 0.000 description 3
229910003460 diamond Inorganic materials 0.000 description 3
239000010432 diamond Substances 0.000 description 3
239000006185 dispersion Substances 0.000 description 3
238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
210000002744 extracellular matrix Anatomy 0.000 description 3
229940012952 fibrinogen Drugs 0.000 description 3
150000004676 glycans Chemical class 0.000 description 3
235000011187 glycerol Nutrition 0.000 description 3
230000002440 hepatic effect Effects 0.000 description 3
239000001863 hydroxypropyl cellulose Substances 0.000 description 3
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
230000006698 induction Effects 0.000 description 3
CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 3
239000006249 magnetic particle Substances 0.000 description 3
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
230000004060 metabolic process Effects 0.000 description 3
229910052750 molybdenum Inorganic materials 0.000 description 3
239000011733 molybdenum Substances 0.000 description 3
238000000465 moulding Methods 0.000 description 3
150000007524 organic acids Chemical class 0.000 description 3
235000005985 organic acids Nutrition 0.000 description 3
229910052762 osmium Inorganic materials 0.000 description 3
SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 3
230000000278 osteoconductive effect Effects 0.000 description 3
229910052763 palladium Inorganic materials 0.000 description 3
230000000144 pharmacologic effect Effects 0.000 description 3
230000000704 physical effect Effects 0.000 description 3
229920001282 polysaccharide Polymers 0.000 description 3
239000005017 polysaccharide Substances 0.000 description 3
230000001737 promoting effect Effects 0.000 description 3
229910052702 rhenium Inorganic materials 0.000 description 3
WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 3
150000004756 silanes Chemical class 0.000 description 3
239000004332 silver Substances 0.000 description 3
239000011343 solid material Substances 0.000 description 3
230000008093 supporting effect Effects 0.000 description 3
229910052723 transition metal Inorganic materials 0.000 description 3
HQYALQRYBUJWDH-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical compound CCC[Si](OC)(OC)OC HQYALQRYBUJWDH-UHFFFAOYSA-N 0.000 description 3
229910052726 zirconium Inorganic materials 0.000 description 3
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
WDJHALXBUFZDSR-UHFFFAOYSA-N Acetoacetic acid Natural products CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 2
108010088751 Albumins Proteins 0.000 description 2
102000009027 Albumins Human genes 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
239000004971 Cross linker Substances 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 2
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 2
102000000589 Interleukin-1 Human genes 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
108010002350 Interleukin-2 Proteins 0.000 description 2
102000000588 Interleukin-2 Human genes 0.000 description 2
102000004889 Interleukin-6 Human genes 0.000 description 2
108090001005 Interleukin-6 Proteins 0.000 description 2
102000004890 Interleukin-8 Human genes 0.000 description 2
108090001007 Interleukin-8 Proteins 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
241000446313 Lamella Species 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
229920001244 Poly(D,L-lactide) Polymers 0.000 description 2
229920002732 Polyanhydride Polymers 0.000 description 2
229920000954 Polyglycolide Polymers 0.000 description 2
229920001710 Polyorthoester Polymers 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 2
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
102000009618 Transforming Growth Factors Human genes 0.000 description 2
108010009583 Transforming Growth Factors Proteins 0.000 description 2
238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
125000003545 alkoxy group Chemical group 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
150000001343 alkyl silanes Chemical class 0.000 description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
238000004873 anchoring Methods 0.000 description 2
125000004429 atom Chemical group 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical class [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 description 2
239000011324 bead Substances 0.000 description 2
150000001558 benzoic acid derivatives Chemical class 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000008468 bone growth Effects 0.000 description 2
239000000872 buffer Substances 0.000 description 2
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
239000005018 casein Substances 0.000 description 2
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
235000021240 caseins Nutrition 0.000 description 2
239000006143 cell culture medium Substances 0.000 description 2
229920006184 cellulose methylcellulose Polymers 0.000 description 2
150000001860 citric acid derivatives Chemical class 0.000 description 2
239000000084 colloidal system Substances 0.000 description 2
229920001940 conductive polymer Polymers 0.000 description 2
239000003431 cross linking reagent Substances 0.000 description 2
LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 2
230000032459 dedifferentiation Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 2
238000002405 diagnostic procedure Methods 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
230000005294 ferromagnetic effect Effects 0.000 description 2
239000002657 fibrous material Substances 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
229910052732 germanium Inorganic materials 0.000 description 2
GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
210000004907 gland Anatomy 0.000 description 2
229920002674 hyaluronan Polymers 0.000 description 2
229960003160 hyaluronic acid Drugs 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
238000007654 immersion Methods 0.000 description 2
238000002513 implantation Methods 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
208000014674 injury Diseases 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
229940100601 interleukin-6 Drugs 0.000 description 2
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 2
229940096397 interleukin-8 Drugs 0.000 description 2
239000003456 ion exchange resin Substances 0.000 description 2
229920003303 ion-exchange polymer Polymers 0.000 description 2
229910052741 iridium Inorganic materials 0.000 description 2
GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
239000012948 isocyanate Substances 0.000 description 2
150000002513 isocyanates Chemical class 0.000 description 2
239000006233 lamp black Substances 0.000 description 2
238000009630 liquid culture Methods 0.000 description 2
229910052744 lithium Inorganic materials 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
210000005228 liver tissue Anatomy 0.000 description 2
239000000395 magnesium oxide Substances 0.000 description 2
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
239000011976 maleic acid Substances 0.000 description 2
150000002688 maleic acid derivatives Chemical class 0.000 description 2
150000004701 malic acid derivatives Chemical class 0.000 description 2
239000007769 metal material Substances 0.000 description 2
239000002923 metal particle Substances 0.000 description 2
BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 2
239000011707 mineral Substances 0.000 description 2
235000010755 mineral Nutrition 0.000 description 2
150000007522 mineralic acids Chemical class 0.000 description 2
229910052758 niobium Inorganic materials 0.000 description 2
239000010955 niobium Substances 0.000 description 2
GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 2
238000010899 nucleation Methods 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
150000003891 oxalate salts Chemical class 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
150000004707 phenolate Chemical class 0.000 description 2
229920001568 phenolic resin Polymers 0.000 description 2
235000021317 phosphate Nutrition 0.000 description 2
125000005498 phthalate group Chemical group 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
239000002745 poly(ortho ester) Substances 0.000 description 2
229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 2
239000000622 polydioxanone Substances 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
229920001444 polymaleic acid Polymers 0.000 description 2
229940002612 prodrug Drugs 0.000 description 2
239000000651 prodrug Substances 0.000 description 2
230000005855 radiation Effects 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
239000010948 rhodium Substances 0.000 description 2
229910052703 rhodium Inorganic materials 0.000 description 2
MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 2
229910052707 ruthenium Inorganic materials 0.000 description 2
150000003873 salicylate salts Chemical class 0.000 description 2
230000028327 secretion Effects 0.000 description 2
239000012056 semi-solid material Substances 0.000 description 2
PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
241000894007 species Species 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
150000003871 sulfonates Chemical class 0.000 description 2
150000003892 tartrate salts Chemical class 0.000 description 2
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
229910052719 titanium Inorganic materials 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 2
150000003624 transition metals Chemical class 0.000 description 2
ZNOCGWVLWPVKAO-UHFFFAOYSA-N trimethoxy(phenyl)silane Chemical compound CO[Si](OC)(OC)C1=CC=CC=C1 ZNOCGWVLWPVKAO-UHFFFAOYSA-N 0.000 description 2
102000003390 tumor necrosis factor Human genes 0.000 description 2
229910052720 vanadium Inorganic materials 0.000 description 2
GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 2
229910052845 zircon Inorganic materials 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
PJRSUKFWFKUDTH-JWDJOUOUSA-N (2s)-6-amino-2-[[2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[(2-aminoacetyl)amino]-4-methylsulfanylbutanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]propanoyl Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O PJRSUKFWFKUDTH-JWDJOUOUSA-N 0.000 description 1
LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
KPJZHOPZRAFDTN-ZRGWGRIASA-N (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@H](CO)CC)C2)=C3C2=CN(C)C3=C1 KPJZHOPZRAFDTN-ZRGWGRIASA-N 0.000 description 1
ZXMGHDIOOHOAAE-UHFFFAOYSA-N 1,1,1-trifluoro-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)NS(=O)(=O)C(F)(F)F ZXMGHDIOOHOAAE-UHFFFAOYSA-N 0.000 description 1
WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical compound [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 description 1
BXBOUPUNKULVKB-UHFFFAOYSA-N 10-trimethoxysilyldecyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCCCCCCCCOC(=O)C(C)=C BXBOUPUNKULVKB-UHFFFAOYSA-N 0.000 description 1
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
UWRZIZXBOLBCON-UHFFFAOYSA-N 2-phenylethenamine Chemical compound NC=CC1=CC=CC=C1 UWRZIZXBOLBCON-UHFFFAOYSA-N 0.000 description 1
ZDZYGYFHTPFREM-UHFFFAOYSA-N 3-[3-aminopropyl(dimethoxy)silyl]oxypropan-1-amine Chemical compound NCCC[Si](OC)(OC)OCCCN ZDZYGYFHTPFREM-UHFFFAOYSA-N 0.000 description 1
HXLAEGYMDGUSBD-UHFFFAOYSA-N 3-[diethoxy(methyl)silyl]propan-1-amine Chemical compound CCO[Si](C)(OCC)CCCN HXLAEGYMDGUSBD-UHFFFAOYSA-N 0.000 description 1
SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
YFICSDVNKFLZRQ-UHFFFAOYSA-N 3-trimethylsilylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](C)(C)C YFICSDVNKFLZRQ-UHFFFAOYSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
XWUCFAJNVTZRLE-UHFFFAOYSA-N 7-thiabicyclo[2.2.1]hepta-1,3,5-triene Chemical compound C1=C(S2)C=CC2=C1 XWUCFAJNVTZRLE-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 1
229910000851 Alloy steel Inorganic materials 0.000 description 1
102400000345 Angiotensin-2 Human genes 0.000 description 1
101800000733 Angiotensin-2 Proteins 0.000 description 1
229910015808 BaTe Inorganic materials 0.000 description 1
229940122361 Bisphosphonate Drugs 0.000 description 1
ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
229910004813 CaTe Inorganic materials 0.000 description 1
102000000905 Cadherin Human genes 0.000 description 1
108050007957 Cadherin Proteins 0.000 description 1
102400000113 Calcitonin Human genes 0.000 description 1
108060001064 Calcitonin Proteins 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
229920000049 Carbon (fiber) Polymers 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
229910004613 CdTe Inorganic materials 0.000 description 1
229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
229910052684 Cerium Inorganic materials 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
229910000531 Co alloy Inorganic materials 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
150000008574 D-amino acids Chemical class 0.000 description 1
GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102400000686 Endothelin-1 Human genes 0.000 description 1
101800004490 Endothelin-1 Proteins 0.000 description 1
102000003951 Erythropoietin Human genes 0.000 description 1
108090000394 Erythropoietin Proteins 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
229920000896 Ethulose Polymers 0.000 description 1
239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
102000009123 Fibrin Human genes 0.000 description 1
108010073385 Fibrin Proteins 0.000 description 1
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
208000005422 Foreign-Body reaction Diseases 0.000 description 1
241000233866 Fungi Species 0.000 description 1
229910002601 GaN Inorganic materials 0.000 description 1
229910005540 GaP Inorganic materials 0.000 description 1
229910005542 GaSb Inorganic materials 0.000 description 1
229910052688 Gadolinium Inorganic materials 0.000 description 1
229910001218 Gallium arsenide Inorganic materials 0.000 description 1
229910000530 Gallium indium arsenide Inorganic materials 0.000 description 1
229920002971 Heparan sulfate Polymers 0.000 description 1
229910004262 HgTe Inorganic materials 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
229910000673 Indium arsenide Inorganic materials 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
239000005058 Isophorone diisocyanate Substances 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
150000008575 L-amino acids Chemical class 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
ODYCAZSSUVCHNU-XLAORIBOSA-N Laurencin Natural products CC[C@H]1C[C@H](CC=CC[C@@H]1Br)[C@@H](CC=CC#C)OC(=O)C ODYCAZSSUVCHNU-XLAORIBOSA-N 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
229910017680 MgTe Inorganic materials 0.000 description 1
229920001730 Moisture cure polyurethane Polymers 0.000 description 1
102000014962 Monocyte Chemoattractant Proteins Human genes 0.000 description 1
108010064136 Monocyte Chemoattractant Proteins Proteins 0.000 description 1
229910052779 Neodymium Inorganic materials 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 1
229920000805 Polyaspartic acid Polymers 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
229920000265 Polyparaphenylene Polymers 0.000 description 1
NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
RWRDLPDLKQPQOW-UHFFFAOYSA-O Pyrrolidinium ion Chemical compound C1CC[NH2+]C1 RWRDLPDLKQPQOW-UHFFFAOYSA-O 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
229910004411 SrTe Inorganic materials 0.000 description 1
239000005864 Sulphur Substances 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
229910052776 Thorium Inorganic materials 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
229910010061 TiC13 Inorganic materials 0.000 description 1
DKJJVAGXPKPDRL-UHFFFAOYSA-N Tiludronic acid Chemical compound OP(O)(=O)C(P(O)(O)=O)SC1=CC=C(Cl)C=C1 DKJJVAGXPKPDRL-UHFFFAOYSA-N 0.000 description 1
DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
102100040247 Tumor necrosis factor Human genes 0.000 description 1
241000700605 Viruses Species 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
229910007709 ZnTe Inorganic materials 0.000 description 1
239000011358 absorbing material Substances 0.000 description 1
229940081735 acetylcellulose Drugs 0.000 description 1
125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
150000001252 acrylic acid derivatives Chemical class 0.000 description 1
229910052768 actinide Inorganic materials 0.000 description 1
150000001255 actinides Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
238000004115 adherent culture Methods 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
230000000274 adsorptive effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000005054 agglomeration Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
229960004343 alendronic acid Drugs 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
229910000287 alkaline earth metal oxide Inorganic materials 0.000 description 1
238000005275 alloying Methods 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
229940024545 aluminum hydroxide Drugs 0.000 description 1
239000002194 amorphous carbon material Substances 0.000 description 1
230000019552 anatomical structure morphogenesis Effects 0.000 description 1
229950006323 angiotensin ii Drugs 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
229940058344 antitrematodals organophosphorous compound Drugs 0.000 description 1
210000001742 aqueous humor Anatomy 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
150000005840 aryl radicals Chemical class 0.000 description 1
210000003567 ascitic fluid Anatomy 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
230000003305 autocrine Effects 0.000 description 1
210000002469 basement membrane Anatomy 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
210000000941 bile Anatomy 0.000 description 1
210000000013 bile duct Anatomy 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
239000005313 bioactive glass Chemical group 0.000 description 1
239000003462 bioceramic Substances 0.000 description 1
238000006065 biodegradation reaction Methods 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
229910052797 bismuth Inorganic materials 0.000 description 1
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
150000004663 bisphosphonates Chemical class 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
238000009835 boiling Methods 0.000 description 1
210000002805 bone matrix Anatomy 0.000 description 1
229910052796 boron Inorganic materials 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
229960002802 bromocriptine Drugs 0.000 description 1
229910052793 cadmium Inorganic materials 0.000 description 1
UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
229960004015 calcitonin Drugs 0.000 description 1
VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
239000001639 calcium acetate Substances 0.000 description 1
235000011092 calcium acetate Nutrition 0.000 description 1
229960005147 calcium acetate Drugs 0.000 description 1
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
239000000920 calcium hydroxide Substances 0.000 description 1
229910001861 calcium hydroxide Inorganic materials 0.000 description 1
BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
239000000292 calcium oxide Substances 0.000 description 1
ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical group [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000006229 carbon black Substances 0.000 description 1
239000004917 carbon fiber Substances 0.000 description 1
239000002041 carbon nanotube Substances 0.000 description 1
229910021393 carbon nanotube Inorganic materials 0.000 description 1
229950005499 carbon tetrachloride Drugs 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
238000005266 casting Methods 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
229940081734 cellulose acetate phthalate Drugs 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 description 1
229960002286 clodronic acid Drugs 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000002322 conducting polymer Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000007797 corrosion Effects 0.000 description 1
238000005260 corrosion Methods 0.000 description 1
150000003983 crown ethers Chemical class 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
229960001425 deferoxamine mesylate Drugs 0.000 description 1
238000007872 degassing Methods 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
229920006237 degradable polymer Polymers 0.000 description 1
239000007857 degradation product Substances 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
238000000280 densification Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
IDDIJAWJANBQLJ-UHFFFAOYSA-N desferrioxamine B mesylate Chemical compound [H+].CS([O-])(=O)=O.CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN IDDIJAWJANBQLJ-UHFFFAOYSA-N 0.000 description 1
238000011161 development Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
230000001079 digestive effect Effects 0.000 description 1
150000002009 diols Chemical class 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
230000005518 electrochemistry Effects 0.000 description 1
239000007772 electrode material Substances 0.000 description 1
210000003060 endolymph Anatomy 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
229940105423 erythropoietin Drugs 0.000 description 1
FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 description 1
NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 1
125000004494 ethyl ester group Chemical group 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
SBRXLTRZCJVAPH-UHFFFAOYSA-N ethyl(trimethoxy)silane Chemical compound CC[Si](OC)(OC)OC SBRXLTRZCJVAPH-UHFFFAOYSA-N 0.000 description 1
229960004585 etidronic acid Drugs 0.000 description 1
210000002907 exocrine cell Anatomy 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
229950003499 fibrin Drugs 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
108010048500 fibroblast stimulating factor-1 Proteins 0.000 description 1
238000007667 floating Methods 0.000 description 1
125000003709 fluoroalkyl group Chemical group 0.000 description 1
238000011010 flushing procedure Methods 0.000 description 1
238000005187 foaming Methods 0.000 description 1
239000011888 foil Substances 0.000 description 1
SLGWESQGEUXWJQ-UHFFFAOYSA-N formaldehyde;phenol Chemical compound O=C.OC1=CC=CC=C1 SLGWESQGEUXWJQ-UHFFFAOYSA-N 0.000 description 1
238000007306 functionalization reaction Methods 0.000 description 1
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
238000001879 gelation Methods 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000007773 growth pattern Effects 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
230000035876 healing Effects 0.000 description 1
210000003709 heart valve Anatomy 0.000 description 1
RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
229960001340 histamine Drugs 0.000 description 1
239000012510 hollow fiber Substances 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
238000005470 impregnation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
WPYVAWXEWQSOGY-UHFFFAOYSA-N indium antimonide Chemical compound [Sb]#[In] WPYVAWXEWQSOGY-UHFFFAOYSA-N 0.000 description 1
RPQDHPTXJYYUPQ-UHFFFAOYSA-N indium arsenide Chemical compound [In]#[As] RPQDHPTXJYYUPQ-UHFFFAOYSA-N 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000001746 injection moulding Methods 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
229920000592 inorganic polymer Polymers 0.000 description 1
229910001867 inorganic solvent Inorganic materials 0.000 description 1
239000003049 inorganic solvent Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000008611 intercellular interaction Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
210000004153 islets of langerhan Anatomy 0.000 description 1
NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
210000001985 kidney epithelial cell Anatomy 0.000 description 1
238000003475 lamination Methods 0.000 description 1
229910052747 lanthanoid Inorganic materials 0.000 description 1
150000002602 lanthanoids Chemical class 0.000 description 1
229910052746 lanthanum Inorganic materials 0.000 description 1
FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
229910052745 lead Inorganic materials 0.000 description 1
239000003446 ligand Substances 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
239000011654 magnesium acetate Substances 0.000 description 1
235000011285 magnesium acetate Nutrition 0.000 description 1
229940069446 magnesium acetate Drugs 0.000 description 1
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
239000000347 magnesium hydroxide Substances 0.000 description 1
229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
210000002901 mesenchymal stem cell Anatomy 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
239000002905 metal composite material Substances 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
125000004492 methyl ester group Chemical group 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
RJMRIDVWCWSWFR-UHFFFAOYSA-N methyl(tripropoxy)silane Chemical compound CCCO[Si](C)(OCCC)OCCC RJMRIDVWCWSWFR-UHFFFAOYSA-N 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
229960001186 methysergide Drugs 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
NHBRUUFBSBSTHM-UHFFFAOYSA-N n'-[2-(3-trimethoxysilylpropylamino)ethyl]ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCNCCN NHBRUUFBSBSTHM-UHFFFAOYSA-N 0.000 description 1
XCOASYLMDUQBHW-UHFFFAOYSA-N n-(3-trimethoxysilylpropyl)butan-1-amine Chemical compound CCCCNCCC[Si](OC)(OC)OC XCOASYLMDUQBHW-UHFFFAOYSA-N 0.000 description 1
HNARGILVWSSFKJ-UHFFFAOYSA-N n-methylheptatriacontan-19-amine Chemical compound CCCCCCCCCCCCCCCCCCC(NC)CCCCCCCCCCCCCCCCCC HNARGILVWSSFKJ-UHFFFAOYSA-N 0.000 description 1
239000002086 nanomaterial Substances 0.000 description 1
QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
210000000944 nerve tissue Anatomy 0.000 description 1
210000003061 neural cell Anatomy 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
150000002823 nitrates Chemical class 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
229910000069 nitrogen hydride Inorganic materials 0.000 description 1
239000012454 non-polar solvent Substances 0.000 description 1
102000044158 nucleic acid binding protein Human genes 0.000 description 1
108700020942 nucleic acid binding protein Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
MSRJTTSHWYDFIU-UHFFFAOYSA-N octyltriethoxysilane Chemical compound CCCCCCCC[Si](OCC)(OCC)OCC MSRJTTSHWYDFIU-UHFFFAOYSA-N 0.000 description 1
229960003493 octyltriethoxysilane Drugs 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
150000002903 organophosphorus compounds Chemical class 0.000 description 1
230000000399 orthopedic effect Effects 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
210000004409 osteocyte Anatomy 0.000 description 1
230000002188 osteogenic effect Effects 0.000 description 1
230000004819 osteoinduction Effects 0.000 description 1
230000002138 osteoinductive effect Effects 0.000 description 1
230000005298 paramagnetic effect Effects 0.000 description 1
230000000849 parathyroid Effects 0.000 description 1
229960001639 penicillamine Drugs 0.000 description 1
108010021753 peptide-Gly-Leu-amide Proteins 0.000 description 1
210000004912 pericardial fluid Anatomy 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
239000005011 phenolic resin Substances 0.000 description 1
FABOKLHQXVRECE-UHFFFAOYSA-N phenyl(tripropoxy)silane Chemical compound CCCO[Si](OCCC)(OCCC)C1=CC=CC=C1 FABOKLHQXVRECE-UHFFFAOYSA-N 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
PARWUHTVGZSQPD-UHFFFAOYSA-N phenylsilane Chemical class [SiH3]C1=CC=CC=C1 PARWUHTVGZSQPD-UHFFFAOYSA-N 0.000 description 1
229940116254 phosphonic acid Drugs 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical class OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
238000005240 physical vapour deposition Methods 0.000 description 1
210000004910 pleural fluid Anatomy 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
229920001078 poly (N-Isopropyl methacrylamide) Polymers 0.000 description 1
229920001977 poly(N,N-diethylacrylamides) Polymers 0.000 description 1
229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
229920001197 polyacetylene Polymers 0.000 description 1
229920000767 polyaniline Polymers 0.000 description 1
108010064470 polyaspartate Proteins 0.000 description 1
229920002643 polyglutamic acid Polymers 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
229920002959 polymer blend Polymers 0.000 description 1
239000012704 polymeric precursor Substances 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229920000128 polypyrrole Polymers 0.000 description 1
229920000123 polythiophene Polymers 0.000 description 1
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
239000010970 precious metal Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000001902 propagating effect Effects 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
210000005234 proximal tubule cell Anatomy 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
239000000376 reactant Substances 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
239000013557 residual solvent Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
229910052706 scandium Inorganic materials 0.000 description 1
SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 description 1
230000008684 selective degradation Effects 0.000 description 1
SBIBMFFZSBJNJF-UHFFFAOYSA-N selenium;zinc Chemical compound [Se]=[Zn] SBIBMFFZSBJNJF-UHFFFAOYSA-N 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
229920000431 shape-memory polymer Polymers 0.000 description 1
229910000077 silane Inorganic materials 0.000 description 1
239000010944 silver (metal) Substances 0.000 description 1
210000002363 skeletal muscle cell Anatomy 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
210000000329 smooth muscle myocyte Anatomy 0.000 description 1
239000011775 sodium fluoride Substances 0.000 description 1
235000013024 sodium fluoride Nutrition 0.000 description 1
BFDWBSRJQZPEEB-UHFFFAOYSA-L sodium fluorophosphate Chemical compound [Na+].[Na+].[O-]P([O-])(F)=O BFDWBSRJQZPEEB-UHFFFAOYSA-L 0.000 description 1
238000000807 solvent casting Methods 0.000 description 1
238000000072 solvent casting and particulate leaching Methods 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
238000004544 sputter deposition Methods 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
229910001256 stainless steel alloy Inorganic materials 0.000 description 1
125000004354 sulfur functional group Chemical group 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
210000001179 synovial fluid Anatomy 0.000 description 1
229920003051 synthetic elastomer Polymers 0.000 description 1
239000005061 synthetic rubber Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
125000005497 tetraalkylphosphonium group Chemical group 0.000 description 1
ZQZCOBSUOFHDEE-UHFFFAOYSA-N tetrapropyl silicate Chemical compound CCCO[Si](OCCC)(OCCC)OCCC ZQZCOBSUOFHDEE-UHFFFAOYSA-N 0.000 description 1
238000007669 thermal treatment Methods 0.000 description 1
229920001169 thermoplastic Polymers 0.000 description 1
229920001187 thermosetting polymer Polymers 0.000 description 1
239000004416 thermosoftening plastic Substances 0.000 description 1
YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 1
DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
229960005324 tiludronic acid Drugs 0.000 description 1
229910052718 tin Inorganic materials 0.000 description 1
XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
229910001428 transition metal ion Inorganic materials 0.000 description 1
230000008733 trauma Effects 0.000 description 1
GYZQBXUDWTVJDF-UHFFFAOYSA-N tributoxy(methyl)silane Chemical compound CCCCO[Si](C)(OCCCC)OCCCC GYZQBXUDWTVJDF-UHFFFAOYSA-N 0.000 description 1
INUOIYMEJLOQFN-UHFFFAOYSA-N tributoxy(phenyl)silane Chemical compound CCCCO[Si](OCCCC)(OCCCC)C1=CC=CC=C1 INUOIYMEJLOQFN-UHFFFAOYSA-N 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
ALVYUZIFSCKIFP-UHFFFAOYSA-N triethoxy(2-methylpropyl)silane Chemical compound CCO[Si](CC(C)C)(OCC)OCC ALVYUZIFSCKIFP-UHFFFAOYSA-N 0.000 description 1
DENFJSAFJTVPJR-UHFFFAOYSA-N triethoxy(ethyl)silane Chemical compound CCO[Si](CC)(OCC)OCC DENFJSAFJTVPJR-UHFFFAOYSA-N 0.000 description 1
CPUDPFPXCZDNGI-UHFFFAOYSA-N triethoxy(methyl)silane Chemical compound CCO[Si](C)(OCC)OCC CPUDPFPXCZDNGI-UHFFFAOYSA-N 0.000 description 1
JCVQKRGIASEUKR-UHFFFAOYSA-N triethoxy(phenyl)silane Chemical compound CCO[Si](OCC)(OCC)C1=CC=CC=C1 JCVQKRGIASEUKR-UHFFFAOYSA-N 0.000 description 1
NBXZNTLFQLUFES-UHFFFAOYSA-N triethoxy(propyl)silane Chemical compound CCC[Si](OCC)(OCC)OCC NBXZNTLFQLUFES-UHFFFAOYSA-N 0.000 description 1
JXUKBNICSRJFAP-UHFFFAOYSA-N triethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](OCC)(OCC)CCCOCC1CO1 JXUKBNICSRJFAP-UHFFFAOYSA-N 0.000 description 1
BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 1
ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
XYJRNCYWTVGEEG-UHFFFAOYSA-N trimethoxy(2-methylpropyl)silane Chemical compound CO[Si](OC)(OC)CC(C)C XYJRNCYWTVGEEG-UHFFFAOYSA-N 0.000 description 1
NMEPHPOFYLLFTK-UHFFFAOYSA-N trimethoxy(octyl)silane Chemical compound CCCCCCCC[Si](OC)(OC)OC NMEPHPOFYLLFTK-UHFFFAOYSA-N 0.000 description 1
BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
210000003606 umbilical vein Anatomy 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
239000013598 vector Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
229910052727 yttrium Inorganic materials 0.000 description 1
VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 description 1
229960004276 zoledronic acid Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/14—Scaffolds; Matrices

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Biochemistry (AREA)
Sustainable Development (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Materials For Medical Uses (AREA)
Prostheses (AREA)

CA002687637A 2007-05-22 2008-05-21 Echafaudages partiellement degradables pour applications biomedicales Abandoned CA2687637A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US93960707P	2007-05-22	2007-05-22
US60/939,607		2007-05-22
PCT/EP2008/056299 WO2008142129A2 (fr)	2007-05-22	2008-05-21	Échafaudages partiellement dégradables pour applications biomédicales

Publications (1)

Publication Number	Publication Date
CA2687637A1 true CA2687637A1 (fr)	2008-11-27

Family

ID=39855181

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002687637A Abandoned CA2687637A1 (fr)	2007-05-22	2008-05-21	Echafaudages partiellement degradables pour applications biomedicales

Country Status (4)

Country	Link
EP (1)	EP2146756A2 (fr)
AU (1)	AU2008252907A1 (fr)
CA (1)	CA2687637A1 (fr)
WO (1)	WO2008142129A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8557288B2 (en)	2008-08-15	2013-10-15	Washington University	Hydrogel microparticle formation in aqueous solvent for biomedical applications
US10240419B2 (en)	2009-12-08	2019-03-26	Baker Hughes, A Ge Company, Llc	Downhole flow inhibition tool and method of unplugging a seat
US9707739B2 (en)	2011-07-22	2017-07-18	Baker Hughes Incorporated	Intermetallic metallic composite, method of manufacture thereof and articles comprising the same
US9033055B2 (en)	2011-08-17	2015-05-19	Baker Hughes Incorporated	Selectively degradable passage restriction and method
US9010416B2 (en)	2012-01-25	2015-04-21	Baker Hughes Incorporated	Tubular anchoring system and a seat for use in the same
WO2014172495A2 (fr) *	2013-04-16	2014-10-23	California Institute Of Technology	Conception, utilisation et fabrication de micro-échafaudages et de nano-échafaudages
US10553875B2 (en)	2013-04-16	2020-02-04	California Institute Of Technology	Use and fabrication of microscaffolds and nanoscaffolds
US9816339B2 (en)	2013-09-03	2017-11-14	Baker Hughes, A Ge Company, Llc	Plug reception assembly and method of reducing restriction in a borehole
CN104414772A (zh) *	2013-09-06	2015-03-18	山东百多安医疗器械有限公司	体内可降解吸收的人工医用组织修复膜
US10689740B2 (en)	2014-04-18	2020-06-23	Terves, LLCq	Galvanically-active in situ formed particles for controlled rate dissolving tools
US11167343B2 (en)	2014-02-21	2021-11-09	Terves, Llc	Galvanically-active in situ formed particles for controlled rate dissolving tools
WO2015127174A1 (fr)	2014-02-21	2015-08-27	Terves, Inc.	Système métallique de désintégration à activation par fluide
GB201410506D0 (en) *	2014-06-12	2014-07-30	Cell Therapy Ltd	Hybrid composition
US10378303B2 (en)	2015-03-05	2019-08-13	Baker Hughes, A Ge Company, Llc	Downhole tool and method of forming the same
CA3012511A1 (fr)	2017-07-27	2019-01-27	Terves Inc.	Composite a matrice metallique degradable
CN109465170A (zh) *	2018-09-26	2019-03-15	湖北大学	一种基于近红外激光响应下快速实现光愈合的涂层及其制备方法和应用
CN113913805B (zh) *	2021-10-20	2023-08-22	中南大学湘雅医院	一种冷喷涂改性层及其应用
WO2025117862A1 (fr) *	2023-12-01	2025-06-05	Allumin8, Inc.	Échafaudages à base de feuilles pliées continues

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1027897B1 (fr) *	1999-02-10	2005-04-13	IsoTis N.V.	Systèmes de régénération du tissus de cartilage
US6328990B1 (en) *	1999-11-12	2001-12-11	The Trustees Of The University Of Pennsylvania	Bioactive, degradable composite for tissue engineering
DE10253634A1 (de) *	2002-11-13	2004-05-27	Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin	Endoprothese

2008
- 2008-05-21 EP EP08759900A patent/EP2146756A2/fr not_active Withdrawn
- 2008-05-21 WO PCT/EP2008/056299 patent/WO2008142129A2/fr not_active Ceased
- 2008-05-21 CA CA002687637A patent/CA2687637A1/fr not_active Abandoned
- 2008-05-21 AU AU2008252907A patent/AU2008252907A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2008252907A1 (en)	2008-11-27
WO2008142129A3 (fr)	2009-02-05
EP2146756A2 (fr)	2010-01-27
WO2008142129A2 (fr)	2008-11-27

Legal Events

Date	Code	Title	Description
2012-05-22	FZDE	Discontinued

Publication	Publication Date	Title
CA2687637A1 (fr)	2008-11-27	Echafaudages partiellement degradables pour applications biomedicales
Galindo et al.	2019	Hydroxyapatite nanoparticle coating on polymer for constructing effective biointeractive interfaces
US20250135426A1 (en)	2025-05-01	Inorganic non-metallic nanoparticle-assembled hydrogel material and application thereof in additive manufacturing technology
US20060216494A1 (en)	2006-09-28	Organic-inorganic nanocomposite coatings for implant materials and methods of preparation thereof
Roveri et al.	2008	The role of biomimetism in developing nanostructured inorganic matrices for drug delivery
Akiyama et al.	2023	Tubular nanomaterials for bone tissue engineering
CN101288780B (zh)	2011-05-25	可降解力学增强型生物玻璃基多孔复合材料及其制备方法
CN101920046A (zh)	2010-12-22	医用材料、人工牙根及医疗材料的制造方法
CN102146577A (zh)	2011-08-10	一种纯钛金属表面微弧氧化处理电解液及其抗菌性生物活性涂层制备方法
Fukui et al.	2008	Bone tissue reaction of nano-hydroxyapatite/collagen composite at the early stage of implantation
CN103566411B (zh)	2015-01-14	一种介孔生物玻璃改性的多孔陶瓷球义眼座及其制备方法
Sánchez Salcedo et al.	2016	Preventing bacterial adhesion on scaffolds for bone tissue engineering
CN101422632A (zh)	2009-05-06	一种羟基磷灰石/藻酸钠纳米复合材料的制备方法
CN101020084A (zh)	2007-08-22	生物陶瓷涂层钛丝烧结多孔钛人工骨的制备方法
CN108904880A (zh)	2018-11-30	一种3d打印pcl-pda-bmp2骨组织工程支架及其制备方法
Pishbin et al.	2015	Bioactive polymer–calcium phosphate composite coatings by electrophoretic deposition
KR101047897B1 (ko)	2011-07-08	단백질 결합형 생체활성유리 나노섬유 및 이의 제조방법
KR20220081320A (ko)	2022-06-15	생체활성 유리 나노입자 기반의 나노시멘트
CN103598919A (zh)	2014-02-26	一种牙种植体表面生物梯度涂层的制备方法
Sharafipour et al.	2020	Meso‐macroporous crack‐free nanohydroxyapatite coatings templated by C12E10 diblock copolymer on Ti6Al4V implant materials toward human osteoblast‐like cells
CN110393821B (zh)	2020-10-02	多孔氧化锌和氧化钽涂层共修饰的人工植入体及其制备方法
KR20160007176A (ko)	2016-01-20	골드 입자로 표면 처리된 임플란트 및 그 제작방법
CN101643645A (zh)	2010-02-10	异硫氰酸荧光素标记的钙磷材料及其制备方法
CN103007347B (zh)	2014-12-10	利用在Ti表面原位合成的TiO2纳米管覆层负载庆大霉素的方法
CN108079369B (zh)	2021-01-12	具有表面纳米结构的硅酸盐骨水泥支架及其制备方法和用途